Export 2761 results:
Author Title [ Type(Desc)] Year
Journal Article
J. B. Patel, Wilson, S. H., Oakes, T. R., Santhanam, P., and Weaver, L. K., “Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury.”, AJNR Am J Neuroradiol, vol. 41, no. 1, pp. 92-99, 2020.
“Structure, Function and Diversity of the Healthy Human Microbiome”, Nature, vol. 486, no. 7402, pp. 207-14, 2012.
H. Microbiome Consortium and Simone, G., “Structure, Function and Diversity of the Healthy Human Microbiome”, Nature, vol. 486, pp. 207-214, 2012.
theS. P. L. I. T. Rese Group, “Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes”, Transplantation, vol. 72, pp. 463-76, 2001.
B. S. Peters, Jaoko, W., Vardas, E., Panayotakopoulos, G., Fast, P., Schmidt, C., Gilmour, J., Bogoshi, M., Omosa-Manyonyi, G., Dally, L., Klavinskis, L., Farah, B., Tarragona, T., Bart, P. - A., Robinson, A., Pieterse, C., Stevens, W., Thomas, R., Barin, B., McMichael, A. J., McIntyre, J. A., Pantaleo, G., Hanke, T., and Bwayo, J., “Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.”, Vaccine, vol. 25, no. 11, pp. 2120-7, 2007.
B. S. Peters, Jaoko, W., Vardas, E., Panayotakopoulos, G., Fast, P., Schmidt, C., Gilmour, J., Bogoshi, M., G Manyonyi, O., Dally, L., Klavinskis, L., Farah, B., Tarragona, T., Bart, P. - A., Robinson, A., Pieterse, C., Stevens, W., Thomas, R., Barin, B., and Bwayo, J. [..], “Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity”, Vaccine, vol. 25, pp. 2120-2127, 2007.
H. W. Bruckner, Lokich, J. J., and Stablein, D. M., “Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.”, Cancer Treat Rep, vol. 66, no. 9, pp. 1713-7, 1982.
S. R. Martin, Atkison, P., Anand, R., and Lindblad, A. S., “Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada.”, Pediatr Transplant, vol. 8, no. 3, pp. 273-83, 2004.
S. V. McDiarmid, Anand, R., and Lindblad, A. S., “Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada”, Pediatr Transplant, vol. 8, pp. 284-94, 2004.
S. V. McDiarmid, Anand, R., and Lindblad, A. S., “Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada.”, Pediatr Transplant, vol. 8, no. 3, pp. 284-94, 2004.
E. Alonso and Anand, R., “Studies of pediatric liver transplantation. School attendance and growth of school age children following liver transplantation”, Transplantation, vol. 69, p. S307, 2000.
S. V. McDiarmid and Anand, R., “Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report.”, Clin Transpl, pp. 119-30, 2003.
S. V. McDiarmid and Anand, R., “Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report”, Clin Transpl, pp. 119-30, 2003.
“Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes.”, Transplantation, vol. 72, no. 3, pp. 463-76, 2001.
D. M. Donovan, Bogenschutz, M. P., Perl, H., Forcehimes, A., Adinoff, B., Mandler, R., Oden, N., and Walker, R., “Study Design to Examine the Potential Role of Assessment Reactivity in Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED) Protocol”, Addict Sci Clin Pract, vol. 7, p. 16, 2012.
D. M. Donovan, Bogenschutz, M. P., Perl, H., Forcehimes, A., Adinoff, B., Mandler, R., Oden, N., and Walker, R., “Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol.”, Addict Sci Clin Pract, vol. 7, p. 16, 2012.
R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R., “A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease”, 2003.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., “Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis”, 2003.
D. M. Fleischer, A Burks, W., Vickery, B. P., Scurlock, A. M., Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A. K., Mayer, L., Lindblad, R., Plaut, M., and Sampson, H. A., “Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.”, J Allergy Clin Immunol, vol. 131, no. 1, pp. 119-27.e1-7, 2013.
D. M. Fleischer, Burks, A. W., Vickery, B. P., Scurlock, A. M., Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A. K., Mayer, L., Lindblad, R., Plaut, M., and Sampson, H. A., “Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial”, J Allergy Clin Immunol, vol. 131, pp. 119-127.e1-7, 2013.
A. W. Burks, Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., Vickery, B. P., Liu, A. H., Henning, A. K., Lindblad, R., Dawson, P., Plaut, M., Sampson, H. A., and CoFAR), T. Consortium, “Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial”, J Allergy Clin Immunol, 2015.
W. A Burks, Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., Vickery, B. P., Liu, A. H., Henning, A. K., Lindblad, R., Dawson, P., Plaut, M., and Sampson, H. A., “Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.”, J Allergy Clin Immunol, vol. 135, no. 5, pp. 1240-8.e1-3, 2015.
J. Robinson-Papp, Gelman, B. B., Grant, I., Singer, E., Gensler, G., and Morgello, S., “Substance abuse increases the risk of neuropathy in an HIV-infected cohort.”, Muscle Nerve, vol. 45, no. 4, pp. 471-6, 2012.
J. Robinson-Papp, Gelman, B., Grant, I., Singer, E., Gensler, G., Morgello, S., and Consortium, N. NeuroA. I. D. S., “Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort”, Muscle & Nerve, vol. 45, pp. 471-476, 2012.
J. McNeely, Wright, S., Matthews, A. G., Rotrosen, J., Shelley, D., Buchholz, M. P., and Curro, F. A., “Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers.”, J Am Dent Assoc, vol. 144, no. 6, pp. 627-38, 2013.